Really good work. You have laid out clear arguments for your hypothesis. And considering that BOT will hit the ground running, it won't be long before we can check against actual results.
- Forums
- ASX - By Stock
- BOT
- Sofdra US Sales Curve
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
9.68%
!
34.0¢

Sofdra US Sales Curve, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $666.7M |
Open | High | Low | Value | Volume |
31.0¢ | 35.0¢ | 31.0¢ | $3.702M | 11.12M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 278570 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 275585 | 0.335 |
12 | 550245 | 0.330 |
7 | 273690 | 0.325 |
8 | 303165 | 0.320 |
12 | 521002 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 115000 | 3 |
0.350 | 169326 | 7 |
0.355 | 173000 | 4 |
0.360 | 92950 | 7 |
0.370 | 260842 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online